user

The impact of steroid-sparing biologic therapies on weight loss in obese individuals with severe eosinophilic asthma

被引：5
|
作者：
Nanzer, Alexandra M. [1 ,2 ]
Taylor, Victoria [1 ]
Hearn, Andrew P. [1 ,2 ]
Kavanagh, Joanne E. [1 ,2 ]
Patrick, Tanya [1 ]
Green, Linda [1 ]
Thomson, Louise [1 ]
Lam, Jodie [1 ]
Fernandes, Mariana [1 ]
Roxas, Cris [1 ]
d'Ancona, Grainne [1 ,2 ]
Kent, Brian D. [1 ,3 ,4 ]
Dhariwal, Jaideep [1 ]
Jackson, David J. [1 ,4 ]
机构：
[1] Guys & St Thomas NHS Fdn Trust, Guys Severe Asthma Serv, London, England
[2] Kings Coll London, Kings Ctr Lung Hlth, Sch Immunol & Microbial Sci, London, England
[3] St James Hosp, Dept Resp Med, Dublin, Ireland
[4] Trinity Coll Dublin, Sch Med, Dublin, Ireland
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷 / 02期
关键词：
MEPOLIZUMAB;
D O I：
10.1183/13993003.00245-2023
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页数：4
相关论文
共 31 条
  • [1] Steroid-sparing effect of mepolizumab in children with severe eosinophilic nonallergic asthma
    Tosca, Maria Angela
    Girosi, Donata
    Sacco, Oliviero
    Bernardini, Roberto
    Ciprandi, Giorgio
    [J]. ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2021, 49 (05) : 113 - 116
  • [2] The efficacy of tiotropium as a steroid-sparing agent in severe asthma
    Kapoor, Anmol S.
    Olsen, Sharla-Rae
    O'Hara, Cindy
    Puttagunta, Lakshmi
    Vethanayagam, Dilini
    [J]. CANADIAN RESPIRATORY JOURNAL, 2009, 16 (03) : 99 - 101
  • [3] IMPACT OF WEIGHT ON STEROID REDUCTION IN PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA TREATED WITH MEPOLIZUMAB
    Katial, R.
    Albers, F.
    Prazma, C.
    Bradford, E.
    Ortega, H.
    Price, R.
    Pouliquen, I.
    Castro, M.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : E3 - E3
  • [4] Non-biologic, steroid-sparing therapies for non-infectious intermediate, posterior, and panuveitis in adults
    Mayhew, Rebecca G. Edwards
    Li, Tianjing
    McCann, Paul
    Leslie, Louis
    Caldwell, Anne Strong
    Palestine, Alan G.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (10):
  • [5] Two-year integrated steroid-sparing analysis and safety of benralizumab for severe asthma
    Bourdin, Arnaud
    Shaw, Dominick
    Menzies-Gow, Andrew
    FitzGerald, J. Mark
    Bleecker, Eugene R.
    Busse, William W.
    Ferguson, Gary T.
    Brooks, Laura
    Barker, Peter
    Garcia Gil, Esther
    Martin, Ubaldo J.
    [J]. JOURNAL OF ASTHMA, 2021, 58 (04) : 514 - 522
  • [6] Effects of weight loss on asthma control in obese patients with severe asthma
    Dias-Junior, Servulo Azevedo
    Reis, Monica
    de Carvalho-Pinto, Regina Maria
    Stelmach, Rafael
    Halpern, Alfredo
    Cukier, Alberto
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2014, 43 (05) : 1368 - 1377
  • [7] SLIGHT STEROID-SPARING EFFECT OF INTRAVENOUS IMMUNOGLOBULIN IN CHILDREN AND ADOLESCENTS WITH MODERATELY SEVERE BRONCHIAL-ASTHMA
    JAKOBSSON, T
    CRONER, S
    KJELLMAN, NIM
    PETTERSSON, A
    VASSELLA, C
    BJORKSTEN, B
    [J]. ALLERGY, 1994, 49 (06) : 413 - 420
  • [8] IMPACT OF WEIGHT ON THE EFFICACY OF MEPOLIZUMAB IN PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA
    Ortega, H.
    Albers, F.
    Llanos-Ackert, J.
    Bradford, E.
    Price, R.
    Pouliquen, I.
    Castro, M.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : E3 - E4
  • [9] Oral steroid-sparing effect of two doses of nebulized fluticasone propionate and placebo in patients with severe chronic asthma
    Westbroek, J
    Saarelainen, S
    Laher, M
    O'Brien, J
    Barnacle, H
    Efthimiou, J
    [J]. RESPIRATORY MEDICINE, 1999, 93 (10) : 689 - 699
  • [10] Long-term corticosteroid use, adrenal insufficiency and the need for steroid-sparing treatment in adult severe asthma
    Gurnell, M.
    Heaney, L. G.
    Price, D.
    Menzies-Gow, A.
    [J]. JOURNAL OF INTERNAL MEDICINE, 2021, 290 (02) : 240 - 256
1234